Phenolphthalein

Phenolphthalein

SCHEMBL951288

O=C1OC(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccccc21.[NaH]

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.97
LMNA P02545 4/20 0.97
MEN1 O00255 3/20 0.97
KMT2A Q03164 3/20 0.97
TDP1 Q9NUW8 3/20 0.97
SMN1; SMN2 Q16637 2/20 0.97
GPR55 Q9Y2T6 2/20 0.97
TYMS P04818 2/20 0.97
ALDH1A1 P00352 1/20 0.97
ESR1 P03372 1/20 0.97
TP53 P04637 1/20 0.97
CYP3A4 P08684 1/20 0.97
ALOX15 P16050 1/20 0.97
TSHR P16473 1/20 0.97
ESR2 Q92731 1/20 0.97
HSD17B10 Q99714 1/20 0.97
CFTR P13569 1/20 0.71
GOPC Q9HD26 1/20 0.71
HSP90AA1 P07900 2/20 0.69
POLB P06746 3/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenolphthalein SCHEMBL3420446 1.00 MAPT (0.97) MAPTLMNAMEN1KMT2ATDP1
Phenolphthalein SCHEMBL27670 0.98 MAPT (1.00) MAPTLMNAMEN1KMT2ATDP1
Phenolphthalein SCHEMBL6139696 0.98 MAPT (1.00) MAPTLMNAMEN1KMT2ATDP1
Phenolphthalein SCHEMBL29362413 0.98 MAPT (1.00) MAPTLMNAMEN1KMT2ATDP1
Phenolphthalein SCHEMBL23929043 0.97 MAPT (0.97) MAPTLMNAMEN1KMT2ATDP1
Phenolphthalein SCHEMBL7479687 0.97 MAPT (0.97) MAPTLMNAMEN1KMT2ATDP1
Phenolphthalein SCHEMBL28007771 0.97 MAPT (0.97) MAPTLMNAMEN1KMT2ATDP1
Phenolphthalein SCHEMBL4749522 0.97 MAPT (0.97) MAPTLMNAMEN1KMT2ATDP1
Phenolphthalein SCHEMBL5958114 0.97 MAPT (0.97) MAPTLMNAMEN1KMT2ATDP1
Phenolphthalein SCHEMBL9292186 0.97 MAPT (0.97) MAPTLMNAMEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102417499-A Preparation method of phenolphthalein complexing agent TIANJIN CHEM REAGENT RES INST 2012-04-18 CN claimed
CN-117949441-A Mammal urine detection product, mammal urine detection system and application thereof 上海能有生物科技有限公司 2024-04-30 CN disclosed
EP-3685139-B1 REACTIVE DEMARCATION TEMPLATE AND METHOD FOR HAZARDOUS CONTAMINANT TESTING BECTON DICKINSON CO (US) 2023-12-13 EP disclosed
US-11385183-B2 Method for detecting copper(II) ions using a hydrazone-based colorimetric sensor KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2022-07-12 US disclosed
US-11360001-B2 Reactive demarcation template for hazardous contaminant testing BECTON, DICKINSON AND COMPANY (US) 2022-06-14 US disclosed
US-20210109027-A1 METHOD FOR DETECTING COPPER(II) IONS USING A HYDRAZONE-BASED COLORIMETRIC SENSOR KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2021-04-15 US disclosed
EP-3685139-A1 REACTIVE DEMARCATION TEMPLATE FOR HAZARDOUS CONTAMINANT TESTING Becton, Dickinson and Company (US) 2020-07-29 EP disclosed
CN-111108363-A Reactivity partition template for harmful pollutant test 贝克顿·迪金森公司 2020-05-05 CN disclosed
CN-209559735-U For guiding the system for collecting noxious pollutant sample BECTON DICKINSON CO 2019-10-29 CN disclosed
WO-2019060266-A1 REACTIVE DEMARCATION TEMPLATE FOR HAZARDOUS CONTAMINANT TESTING BECTON, DICKINSON AND COMPANY (US) 2019-03-28 WO disclosed
CN-102417499-A Preparation method of phenolphthalein complexing agent TIANJIN CHEM REAGENT RES INST 2012-04-18 CN disclosed
CN-102417499-A Preparation method of phenolphthalein complexing agent TIANJIN CHEM REAGENT RES INST 2012-04-18 CN disclosed
WO-2011113436-A1 A method for promotion of hemostasis and/or wound healing Ferrosan Medical Devices A/S (DK) 2011-09-22 WO disclosed
CN-102014973-A Device for promotion of hemostasis and/or wound healing FERROSAN AS (DK) 2011-04-13 CN disclosed
US-20110021964-A1 Device for Promotion of Hemostasis and/or Wound Healing Ferrosan Medical Devices A/S (DK) 2011-01-27 US disclosed
EP-2259803-A2 DEVICE FOR PROMOTION OF HEMOSTASIS AND/OR WOUND HEALING Ferrosan Medical Devices A/S (DK) 2010-12-15 EP disclosed
US-20090286579-A1 Intelligent Wireless Device Indicator EMBARQ HOLDINGS COMPANY, LLC 2009-11-19 US disclosed
WO-2009109194-A2 DEVICE FOR PROMOTION OF HEMOSTASIS AND/OR WOUND HEALING FERROSAN A/S (DK) 2009-09-11 WO disclosed
CN-1186410-C Hydrolytic blackboard-writing ink composition FAN YUANHUA (CN) 2005-01-26 CN disclosed
CN-1448448-A Hydrolytic blackboard-writing ink composition FAN YUANHUA (CN) 2003-10-15 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11385183-B2 Method for detecting copper(II) ions using a hydrazone-based colorimetric sensor FTH1, GGH, FECH MAPT 3768/4885LMNA 3034/4885MEN1 4150/4885
US-20210109027-A1 METHOD FOR DETECTING COPPER(II) IONS USING A HYDRAZONE-BASED COLORIMETRIC SENSOR FTH1, GGH, FECH MAPT 3768/4885LMNA 3034/4885MEN1 4150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.